Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Marinos C. Dalakas MD, FAAN Advisory Board

Argye Elizabeth Hillis MD, MA Associate Editor

See All Experts

story of the week

Published in Neurology and

Journal Scan / Research · March 16, 2023

Efficacy and Safety of Ravulizumab in Patients With Aquaporin-4–Positive NMOSD

Annals of Neurology

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Michael Levy MD, PhD

Ahmed Obeidat MD, PhD

Annals of Neurology

Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder

Ann. Neurol 2023 Mar 03;[EPub Ahead of Print], SJ Pittock, M Barnett, JL Bennett, A Berthele, J de Seze, M Levy, I Nakashima, C Oreja-Guevara, J Palace, F Paul, C Pozzilli, M Yountz, K Allen, Y Mashhoon, HJ Kim

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Multiple Sclerosis

Efficacy and Safety of Ravulizumab in Patients With Aquaporin-4–Positive NMOSD

Additional Info

Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder

Further Reading

Neurobehavioral Therapy in Patients With Traumatic Brain Injury and Functional Seizures or Epilepsy

Endovascular Treatment vs Medical Management for Basilar Artery Occlusion With Low to Moderate Symptoms

Multisite Skin Biopsies vs CSF Testing for Prion Seeding Activity in the Diagnosis of Prion Diseases

Rate of Autoimmune Encephalitis Among Children With First-Episode Psychosis

Safety, Tolerability, and Efficacy of Subcutaneous Efgartigimod in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Association Between Antiseizure Medication Use and Cardiovascular Events in Older People With Epilepsy

Lower Doses of Rituximab Are Associated With Increased Rates of NMOSD Relapses

Dried Blood Is Nearly as Good as Serum for AQP4 Antibody Testing for Neuromyelitis Optica

Impact of Restrictive vs Liberal Transfusion Strategy on Neurological Outcomes in Patients With Acute Brain Injury

Hematologic Cancer After Gene Therapy for Cerebral Adrenoleukodystrophy

World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Participants

Recently Updated